• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们所了解的经直肠前列腺活检的并发症。3350 例患者的国际多中心研究。

Complications of transrectal prostate biopsy in our context. International multicenter study of 3350 patients.

机构信息

Hospital Arnau de Vilanova, Valencia, España.

Hospital Universitario de Salamanca, Salamanca, España.

出版信息

Actas Urol Esp (Engl Ed). 2020 Apr;44(3):196-204. doi: 10.1016/j.acuro.2019.11.004. Epub 2020 Feb 29.

DOI:10.1016/j.acuro.2019.11.004
PMID:32127231
Abstract

INTRODUCTION

Prostate cancer is the most common visceral neoplasm in men and the second one in the United States with the highest mortality behind lung cancer and ahead of colorectal cancer. While prostate cancer mortality rates have been reduced in the United States, Austria, United Kingdom and France, 5-year survival rates have been incremented in Sweden, probably due to a higher diagnostic activity and non-lethal tumor detection. TRPB usually has low rates of serious complications, with a not negligible number of minor complications. Mortality directly associated with this procedure is low and usually related to septic shock. The main complications derived from prostate biopsy can be infectious (mild or severe) and non-infectious (hematuria consistent with hemorrhage, urethral bleeding, rectal bleeding or hemospermia, acute urinary retention, pain or vasovagal reactions).

MATERIAL AND METHOD

The objective of the study is to compare three usual TRPB protocols and their relationship with the incidence of complications. Retrospective multicenter observational study conducted in three countries (Spain, Italy and Portugal). We have reviewed the medical records of 3350 men who underwent TRPB to evaluate the existence of prostate cancer, with a minimum evolutionary control of 6months.

RESULTS

The mean age was 65,50years, median 66, range 43-79. The subgroup analysis showed that younger patients had higher rates of acute urine retention (AUR) (P=.0000001). Likewise, our results revealed that younger patients presented more procedural pain (P=.0000001) than older patients. Regarding PSA, the mean value was 10.44, SD 7.73, median 8.15, range 0.98-68.09. A higher body mass index (BMI) was not associated with further infection (P=.000004). When performing the multivariate analysis, it was found that the significant variables in the general group were: age (P=.0013), PSA (P=.0402), local infiltration anesthesia (P=.0001) and prophylaxis with metronidazole +tobramycin +amoxicillin/clavulanic acid +gentamicin (P=.0001), presenting a normal distribution with high confidence interval (95%) and significant correlation. Prophylaxis is the most significant variable for no complications and pain (P=.0001), age (P=.0013) and prophylaxis (P=.0001) are for bleeding, age (P=.0013), prophylaxis and PSA (P=.0001) are for infection, and finally, age (P=.0013), anesthesia with local infiltration and prophylaxis (P=.0001) and PSA (P=.0402) are for AUR.

CONCLUSIONS

Sedation has fewer side effects and complications related to the transrectal prostate biopsy procedure with respect to transrectal local anesthesia. The choice of the antibiotic prophylaxis scheme is decisive in the onset of complications arising from the performance of a transrectal prostate biopsy.

摘要

简介

前列腺癌是男性最常见的内脏肿瘤,也是美国第二大癌症,死亡率仅次于肺癌,高于结直肠癌。尽管美国、奥地利、英国和法国的前列腺癌死亡率有所下降,但瑞典的 5 年生存率却有所提高,这可能是由于诊断活动和非致命性肿瘤检测的增加。TRPB 通常具有较低的严重并发症发生率,但也有不可忽视的少数并发症。与该手术直接相关的死亡率较低,通常与感染性休克有关。前列腺活检的主要并发症可以是感染性的(轻度或重度)或非感染性的(血尿伴出血、尿道出血、直肠出血或血精、急性尿潴留、疼痛或血管迷走性反应)。

材料和方法

本研究的目的是比较三种常用的 TRPB 方案及其与并发症发生率的关系。这是一项在三个国家(西班牙、意大利和葡萄牙)进行的回顾性多中心观察性研究。我们回顾了 3350 名接受 TRPB 以评估前列腺癌存在的男性的医疗记录,最低随访时间为 6 个月。

结果

平均年龄为 65.5 岁,中位数为 66 岁,范围为 43-79 岁。亚组分析显示,年轻患者发生急性尿潴留(AUR)的比例更高(P=.0000001)。同样,我们的结果显示,年轻患者的手术疼痛发生率高于老年患者(P=.0000001)。至于 PSA,平均值为 10.44,标准差为 7.73,中位数为 8.15,范围为 0.98-68.09。较高的体重指数(BMI)与进一步感染无关(P=.000004)。在进行多变量分析时,发现一般组中显著的变量是:年龄(P=.0013)、PSA(P=.0402)、局部浸润麻醉(P=.0001)和使用甲硝唑+妥布霉素+阿莫西林/克拉维酸+庆大霉素预防(P=.0001),呈正态分布,置信区间高(95%)且相关性显著。预防是无并发症和疼痛的最重要变量(P=.0001),年龄(P=.0013)和预防(P=.0001)是出血的最重要变量,年龄(P=.0013)、预防和 PSA(P=.0001)是感染的最重要变量,最后,年龄(P=.0013)、局部浸润麻醉和预防(P=.0001)以及 PSA(P=.0402)是 AUR 的最重要变量。

结论

与经直肠局部麻醉相比,镇静具有较少与经直肠前列腺活检手术相关的副作用和并发症。抗生素预防方案的选择对经直肠前列腺活检引起的并发症的发生有决定性影响。

相似文献

1
Complications of transrectal prostate biopsy in our context. International multicenter study of 3350 patients.我们所了解的经直肠前列腺活检的并发症。3350 例患者的国际多中心研究。
Actas Urol Esp (Engl Ed). 2020 Apr;44(3):196-204. doi: 10.1016/j.acuro.2019.11.004. Epub 2020 Feb 29.
2
Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.经直肠前列腺活检后单剂与长程氟喹诺酮类预防用药的比较及感染性并发症的危险因素。
Balkan Med J. 2018 Sep 21;35(5):373-377. doi: 10.4274/balkanmedj.2018.0477. Epub 2018 Jun 5.
3
Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.磷霉素氨丁三醇预防经直肠前列腺活检的有效性和安全性。与环丙沙星的前瞻性随机对照比较。
Actas Urol Esp. 2014 Jul-Aug;38(6):391-6. doi: 10.1016/j.acuro.2014.01.002. Epub 2014 Apr 26.
4
Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study.复方新诺明与经直肠前列腺活检的靶向抗生素预防:一项单中心研究。
World J Urol. 2024 Apr 25;42(1):260. doi: 10.1007/s00345-024-04969-4.
5
Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication Rates.一项大型随机试验表明,由于并发症发生率低,抗菌润滑剂并未降低经直肠前列腺活检患者的感染率。
Eur Urol Focus. 2019 Nov;5(6):992-997. doi: 10.1016/j.euf.2018.06.005. Epub 2018 Jun 23.
6
Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches - a single center preliminary study.经直肠与经会阴前列腺活检术的癌症检出率和并发症比较——单中心初步研究。
BMC Urol. 2019 Oct 28;19(1):101. doi: 10.1186/s12894-019-0539-4.
7
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.前列腺特异性抗原检测癌症的男性前列腺活检的短期结局:ProtecT 研究中的前瞻性评估。
BMJ. 2012 Jan 9;344:d7894. doi: 10.1136/bmj.d7894.
8
[Adverse effects of transrectal prostatic biopsy. Analysis of 303 procedures].[经直肠前列腺活检的不良反应。303例操作分析]
Actas Urol Esp. 2001 Jan;25(1):46-9. doi: 10.1016/s0210-4806(01)72565-x.
9
The eternal enigma in prostatic biopsy access route.前列腺活检穿刺路径中的永恒谜题。
Arch Ital Urol Androl. 2017 Oct 3;89(3):245-246. doi: 10.4081/aiua.2017.3.245.
10
[Descriptive analysis of adverse events associated with transrectal prostatic biopsy after 603 procedures].[603例经直肠前列腺穿刺活检术后不良事件的描述性分析]
Arch Esp Urol. 2004 Jul-Aug;57(6):601-5.

引用本文的文献

1
Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study.在 EMA 警告时代之间接受过前列腺活检的患者中使用抗生素预防:氟喹诺酮类药物在糖尿病和非糖尿病患者中的作用。一项观察性队列研究的结果。
World J Urol. 2022 Aug;40(8):2025-2031. doi: 10.1007/s00345-022-04055-7. Epub 2022 Jun 10.